2.1 Chemicals and characterization
All chemical were obtained from Aldrich or Merck and were used without further purifications unless otherwise stated. The crystalline structure was analyzed by X-ray diffraction (D8/Advance-Bruker) using Cu Kα radiation (λ= 1.54 Å). Morphology and grain size were studied by Field-Emission Scanning electron microscope (FE-SEM) model MIRA3/XMU instrument and operated at 10 kV. Specific surface areas of the sample was determined by N2 adsorption isotherms at 77K on a BELSORP-mini II (MicrotracBEL Corp.), the specific surface area was evaluated using the BET equation. The melting points of products were determined with an Electrothermal 9200 melting point apparatus. The FTIR was provided by Perkin Elmer BX II while the 1HNMR and 13CNMR spectra were provided on Bruker DRX-400 and DRX-300 Avance instruments in CDCl3. The specific surface area was determined by the BET (Brunauere-Emmette-Teller) method [15], while the mesopore size distribution was calculated using BJH (Barrette-Joynere-Halenda) method [16].
2.2 Preparation of Zinc Chromite nanomaterials
In a typical synthesis, zinc nitrate (Zn(NO3)2.6H2O) and chromium nitrate (Cr(NO3)2.9H2O) were used to synthesize zinc chromite. Initially, an appropriate amount of zinc nitrate and chromium nitrate with molar compositions of the 1:2 = (Zn:Cr) were introduced into 40 mL of water to form an aqueous solution. After 15 min of vigorous stirring, NaOH was added drop-wise to adjust the pH of the solution (pH=12.0). Then the mixture was stirred for 1 hr at room temperature. Afterward, the mixture was transformed into an autoclave at 220°C for 24 h in an electric oven without shaking or stirring. Next, the autoclave was allowed to cool to room temperature gradually. The collected precipitate was washed multiple times with ethanol and distilled water to remove any possible impurities. The final product was then heated at 80°C and dried under vacuum for 15 h.
2.3 General procedure for the synthesis of Flavonoids
All the starting compounds 1-(2-hydroxyphenyl)-3-arylpropane-1,3-dione 4 for the synthesis of flavonoids were obtained by a two-steps procedure (scheme 1) according to the reported literature [17]. Then to synthesize flavonoids (scheme 2), 10% w/w of catalyst was mixed with 1mmol 1-(2-hydroxyphenyl)-3-arylpropane-1,3-dione and was stirred at 90°C in solvent-free condition for 10 min. Next, the mixture was filtered and washed with CH2Cl2 to separate the catalyst. To afford the pure product, the solid residue was washed with petroleum ether then recrystallized from H2O/EtOH.
2-phenyl-4H-chromen-4-one (5a, C15H10O2). White crystals, (90%); mp 95-96 °C; 1H NMR (250 MHz, CDCl3): d 8.1-8.2 (m, 1H), 7.91-7.95 (m, 2H), 7.67-7.74 (m, 1H), 7.52-7.59 (m, 4H), 7.40-7.46 (m, 1H), 6.85 (s, 1H); 13C NMR (62 MHz, CDCl3): d 178.5, 163.3, 156.2, 133.8, 131.6, 129.07, 126.3, 125.7, 125.2, 118.1, 107.5.
2-(4-chlorophenyl)-4H-chromen-4-one (5b, C15H9ClO2). White crystals, (95%); m.p. 190-191 °C; 1H NMR (250 MHz, CDCl3): δH/ppm 8.22-8.25 (m, 1H), 7.83-7.89 (m, 2H), 7.69-7.75 (m, 1H), 7.41-7.59 (m, 4H), 6.81 (s, 1H); 13C NMR (62 MHz, CDCl3): δC/ppm 178.3, 161.5, 156.1, 138.1, 133.9, 129.4, 127.5, 125.7, 125.4, 124.0, 122.9, 118.05, 107.6.
2-(4-bromophenyl)-4H-chromen-4-one (5c, C15H9BrO2). White crystals, (95%); m.p. 181-182 °C; 1H NMR (250 MHz, CDCl3): δH/ppm 8.21-8.24 (m, 1H), 7.75-7.82 (m, 2H), 7.65-7.72 (m, 3H), 7.53-7.58 (m, 1H), 7.40-7.46 (m, 1H), 6.81 (s, 1H); 13C NMR (62 MHz, CDCl3): δC/ppm 178.2, 162.3, 156.1, 133.9, 132.3, 130.7, 127.7, 126.3, 125.7, 125.4, 123.8, 118.07, 107.6.
2-(3-chlorophenyl)-4H-chromen-4-one (5d, C15H9ClO2). White crystals, (92%); m.p. 118-120 °C; 1H NMR (250 MHz, CDCl3): δH/ppm 8.20-8.24 (m, 1H), 7.91-7.93 (m, 1H), 7.68-7.8 (m, 2H), 7.43-7.59 (m, 4H), 6.8 (s, 1H); 13C NMR (62 MHz, CDCl3): δC/ppm 178.3, 161.8, 156.1, 135.26, 134.04, 133.5, 131.5, 130.3, 126.3, 125.7, 125.4, 124.3, 123.8, 118.1, 108.1.
2-(4-methoxyphenyl)-4H-chromen-4-one (5e, C16H12O3). White crystals, (93%); m.p. 158-159 °C; 1H NMR (250 MHz, CDCl3): δH/ppm 8.19-8.23 (m, 1H), 7.84-7.89 (m, 2H), 7.63-7.7 (m, 1H), 7.51-7.54 (m, 1H), 7.36-7.42 (m, 1H), 6.98-7.03 (m, 2H), 6.7(s, 1H), 3.8 (s, 3H); 13C NMR (62 MHz, CDCl3): δC/ppm 178.3, 163.3, 162.3, 156.1, 133.5, 127.9, 125.6, 125.05, 123.98, 123.91, 117.4, 114.4, 106.1, 55.4.
2-(2,4-dichlorophenyl)-4H-chromen-4-one (5f, C15H8Cl2O2). White crystals, (97%); m.p. 129-130 °C; 1H NMR (250 MHz, CDCl3): δH/ppm 8.15-8.19 (m, 1H), 7.60-7.64 (m, 1H), 7.45-7.54 (m, 2H), 7.31-7.41 (m, 3H), 7.1 (s, 1H); 13C NMR (62 MHz, CDCl3): δC/ppm 177.9, 161.4, 156.5, 137.3, 134.03, 133.7, 131.3, 130.7, 130.3, 127.5, 125.7, 125.4, 123.7, 118.1, 113.1.
2-p-tolyl-4H-chromen-4-one (5g, C16H12O2). White crystals, (93%); m.p. 112-113 °C; 1H NMR (250 MHz, CDCl3): δH/ppm 8.13-8.16 (m, 1H), 7.72-7.75 (m, 2H), 7.58-7.64 (m, 1H), 7.46-7.49 (m, 1H), 7.29-7.36 (m, 1H), 7.18-7.25 (m, 2H), 6.7 (s, 1H), 2.35 (s, 3H); 13C NMR (62 MHz, CDCl3): δC/ppm 178.4, 163.5, 142.1, 156.2, 133.6, 128.9, 126.2, 125.6, 125.1, 123.9, 118.04, 106.95, 21.53.
2-(2-chlorophenyl)-4H-chromen-4-one (5h, C15H9ClO2). White crystals, (93%); m.p. 115-117 °C; 1H NMR (250 MHz, CDCl3): δH/ppm 8.17-8.2 (m, 1H), 7.55-7.64 (m, 3H), 7.37-7.46 (m, 3H), 7.19 (s, 1H), 6.58 (s, 1H); 13C NMR (62 MHz, CDCl3): δC/ppm 178.1, 162.6, 159.8, 151.3, 133.9, 132.9, 131.7, 130.8, 130.6, 127.09, 125.7, 125.3, 123.8, 118.1, 113.02.
2-(4-fluorophenyl)-4H-chromen-4-one (5i, C15H9FO2). White crystals, (87%); m.p. 149-150 °C; 1H NMR (250 MHz, CDCl3): δH/ppm 8.1-8.2 (m, 1H), 7.85-7.9 (m, 2H), 7.61-7.67 (m, 1H), 7.4-7.6 (m, 1H), 7.34-7.4 (m, 1H), 7.19-7.21 (m, 2H), 6.71 (s, 1H); 13C NMR (62 MHz, CDCl3): δC/ppm 205.5, 174, 151.7, 148.5, 139.3, 133.8, 128.5, 125.7, 125.3, 118.01, 116.4, 116.1, 107.3.